Premium
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
Aptose Biosciences Announces Approval for Listing on the NASDAQ Capital Market Shares to Begin Trading Under the Symbol APTO PR Newswire SAN DIEGO and TORONTO, Oct. 21, 2014 SAN DIEGO and...
Aptose Biosciences to Present at the 2014 BIO Investor Forum PR Newswire SAN DIEGO and TORONTO, Oct. 3, 2014 SAN DIEGO and TORONTO, Oct. 3, 2014 /PRNewswire/ - Aptose Biosciences Inc. (TSX:...
Aptose Biosciences Announces Reverse Stock Split PR Newswire SAN DIEGO and TORONTO, Oct. 1, 2014 SAN DIEGO and TORONTO, Oct. 1, 2014 /PRNewswire/ - Aptose Biosciences Inc. (TSX: APS), a...
Aptose Biosciences Joins The Leukemia & Lymphoma Society's Groundbreaking Beat AML Research Initiative with Oregon Health & Science University PR Newswire 29, 2014 Expansion of...
Aptose Biosciences to Present at Upcoming Investor Conferences PR Newswire SAN DIEGO, CA AND TORONTO, Sept. 25, 2014 SAN DIEGO, CA AND TORONTO, Sept. 25, 2014 /PRNewswire/ - Aptose Biosciences...
Aptose Biosciences Recruits Stephen B. Howell, M.D. to Act in the Capacity of Chief Medical Officer PR Newswire SAN DIEGO and TORONTO, Sept. 8, 2014 SAN DIEGO and TORONTO, Sept. 8, 2014...
Lorus Therapeutics Implements Name Change to Aptose Biosciences PR Newswire TORONTO, Sept. 2, 2014 TORONTO, Sept. 2, 2014 /PRNewswire/ - Lorus Therapeutics Inc. (TSX: LOR) (the...
Lorus Therapeutics Announces Results of Annual and Special Meeting of Shareholders PR Newswire TORONTO, Aug. 19, 2014 TORONTO, Aug. 19, 2014 /PRNewswire/ - Lorus Therapeutics Inc. (TSX: LOR...
Lorus Therapeutics to Present at the Canaccord Genuity 34th Annual Growth Conference PR Newswire TORONTO, Aug. 7, 2014 TORONTO, Aug. 7, 2014 /PRNewswire/ - Lorus Therapeutics Inc. (TSX: LOR...
Lorus Therapeutics Receives FDA Clearance of IND to Initiate LOR-253 Clinical Program in Patients with AML, MDS and other Blood Cancers PR Newswire TORONTO, July 28, 2014 TORONTO, July 28, 2014...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| 260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
